Novo Nordisk AS - Company Profile
Powered by 
All the sales intelligence you need on Novo Nordisk AS in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Novo Nordisk AS fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Novo Nordisk AS.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View more- Top 10 Pharmaceutical Companies in Europe in 2022 by Market Capitalization
- Top 10 Big Biopharma Companies (Large Pharma & Large Biotech) in Europe in 2021 by Revenues
- Top 10 Pharma Companies in Europe in 2021 by R&D Expenditure
- Top 10 Pharmaceutical Companies in the World in 2022 by Market Capitalization
Novo Nordisk AS (Novo Nordisk), a subsidiary of Novo Holdings AS, is a pharmaceutical company. The business performance of the diabetes and obesity care segment, strong market position, focus on R&D and geographical presence are the major strengths of the company, even as debt levels and financial leverage could be a major cause for concern. Global Pharmaceutical market, acquisition of Akero, and contracts and agreements could benefit the company. However, patent expiries, operational risks, and competition and technological changes could affect the company’s market position.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer